• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向肿瘤中的铁死亡:新型海洋来源化合物作为脂质过氧化和谷胱甘肽过氧化物酶4信号通路的调节剂

Targeting Ferroptosis in Tumors: Novel Marine-Derived Compounds as Regulators of Lipid Peroxidation and GPX4 Signaling.

作者信息

Wu Yimao, Chen Xiaoyan, Chen Zichang, Ma Yunqi

机构信息

School of Pharmacy, Binzhou Medical University, Yantai 264003, China.

Second Clinical Medical College, Guangdong Medical University, Dongguan 523808, China.

出版信息

Mar Drugs. 2025 Jun 19;23(6):258. doi: 10.3390/md23060258.

DOI:10.3390/md23060258
PMID:40559667
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12194754/
Abstract

This article reviews the mechanisms by which marine natural products regulate ferroptosis and their potential applications in tumor therapy. Ferroptosis is a form of programmed cell death driven by iron-dependent lipid peroxidation, characterized primarily by the accumulation of lipid peroxides and the failure of antioxidant defense systems. Due to their unique chemical structural diversity, marine natural products demonstrate significant advantages in regulating the ferroptosis pathway. Studies showed that marine compounds target key molecules such as glutathione peroxidase 4 (GPX4) and long-chain acyl-CoA synthetase 4 (ACSL4(a)) ACSL4(1) to modulate lipid peroxidation and iron metabolism, inducing ferroptosis in tumor cells and reshaping the tumor microenvironment (TME). In addition, marine compounds can enhance anti-tumor effects by activating immune responses. Although marine compounds hold great potential in regulating ferroptosis, their clinical translation faces challenges such as low bioavailability and tumor type dependency. Future research needs to integrate multi-omics techniques to further analyze the mechanisms of marine compounds and develop precision therapeutic strategies based on marine compounds to overcome the bottlenecks in ferroptosis therapy.

摘要

本文综述了海洋天然产物调节铁死亡的机制及其在肿瘤治疗中的潜在应用。铁死亡是一种由铁依赖性脂质过氧化驱动的程序性细胞死亡形式,主要特征是脂质过氧化物的积累和抗氧化防御系统的失效。由于其独特的化学结构多样性,海洋天然产物在调节铁死亡途径方面具有显著优势。研究表明,海洋化合物靶向谷胱甘肽过氧化物酶4(GPX4)和长链酰基辅酶A合成酶4(ACSL4(a))、ACSL4(1)等关键分子,调节脂质过氧化和铁代谢,诱导肿瘤细胞铁死亡并重塑肿瘤微环境(TME)。此外,海洋化合物可通过激活免疫反应增强抗肿瘤作用。尽管海洋化合物在调节铁死亡方面具有巨大潜力,但其临床转化面临生物利用度低和肿瘤类型依赖性等挑战。未来的研究需要整合多组学技术,进一步分析海洋化合物的作用机制,并基于海洋化合物开发精准治疗策略,以克服铁死亡治疗中的瓶颈。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/6813c45c42a8/marinedrugs-23-00258-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/08f4190323ab/marinedrugs-23-00258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/4102347ff547/marinedrugs-23-00258-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/886c33a6bff5/marinedrugs-23-00258-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/97bcb3828bae/marinedrugs-23-00258-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/1e9a270ab721/marinedrugs-23-00258-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/6813c45c42a8/marinedrugs-23-00258-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/08f4190323ab/marinedrugs-23-00258-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/4102347ff547/marinedrugs-23-00258-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/886c33a6bff5/marinedrugs-23-00258-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/97bcb3828bae/marinedrugs-23-00258-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/1e9a270ab721/marinedrugs-23-00258-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f61c/12194754/6813c45c42a8/marinedrugs-23-00258-g006.jpg

相似文献

1
Targeting Ferroptosis in Tumors: Novel Marine-Derived Compounds as Regulators of Lipid Peroxidation and GPX4 Signaling.靶向肿瘤中的铁死亡:新型海洋来源化合物作为脂质过氧化和谷胱甘肽过氧化物酶4信号通路的调节剂
Mar Drugs. 2025 Jun 19;23(6):258. doi: 10.3390/md23060258.
2
Low dose radiotherapy combined with immune checkpoint inhibitors induces ferroptosis in lung cancer via the Nrf2/HO-1/GPX4 axis.低剂量放疗联合免疫检查点抑制剂通过Nrf2/HO-1/GPX4轴诱导肺癌细胞发生铁死亡。
Front Immunol. 2025 May 27;16:1558814. doi: 10.3389/fimmu.2025.1558814. eCollection 2025.
3
Targeting ferroptosis: a promising avenue for ovarian cancer treatment.靶向铁死亡:卵巢癌治疗的一条有前景的途径。
Front Immunol. 2025 Jun 5;16:1578723. doi: 10.3389/fimmu.2025.1578723. eCollection 2025.
4
Mechanism of Plantamajoside in inhibiting ferroptosis of pancreatic β cells and treatment of T2DM via activation of the xCT/GPX4 pathway.大车前苷通过激活xCT/GPX4途径抑制胰腺β细胞铁死亡及治疗2型糖尿病的机制
PLoS One. 2025 Jun 20;20(6):e0325674. doi: 10.1371/journal.pone.0325674. eCollection 2025.
5
Phytochemicals as modulators of ferroptosis: a novel therapeutic avenue in cancer and neurodegeneration.植物化学物质作为铁死亡的调节剂:癌症和神经退行性疾病治疗的新途径。
Mol Biol Rep. 2025 Jun 25;52(1):636. doi: 10.1007/s11033-025-10752-4.
6
The role of the NcRNA/ferroptosis axis in lung cancer: molecular mechanisms and potential therapeutic targets.非编码RNA/铁死亡轴在肺癌中的作用:分子机制与潜在治疗靶点
Apoptosis. 2025 Jun 22. doi: 10.1007/s10495-025-02127-8.
7
Phoenixin-14 Alleviates Premature Ovarian Failure by Inhibiting Ferroptosis Through SLC7A11/GPX4.凤尿环肽-14通过SLC7A11/谷胱甘肽过氧化物酶4抑制铁死亡来减轻卵巢早衰。
Drug Dev Res. 2025 Aug;86(5):e70110. doi: 10.1002/ddr.70110.
8
Tanshinone IIA Promotes Functional Recovery After Spinal Cord Injury by Inhibiting Neuron and Oligodendrocyte Ferroptosis Through the GPX4/ACSL4 Axis.丹参酮IIA通过GPX4/ACSL4轴抑制神经元和少突胶质细胞铁死亡促进脊髓损伤后的功能恢复。
Neurochem Res. 2025 May 16;50(3):167. doi: 10.1007/s11064-025-04414-x.
9
Hypoxia induced lipid droplet accumulation promotes resistance to ferroptosis in prostate cancer.缺氧诱导的脂滴积累促进前列腺癌对铁死亡的抗性。
Oncotarget. 2025 Jun 25;16:532-544. doi: 10.18632/oncotarget.28750.
10
Dynamic regulators of ferroptosis: Post-translational modifications in ferroptotic cell death.铁死亡的动态调节因子:铁死亡性细胞死亡中的翻译后修饰
Pharmacol Res. 2025 Jul;217:107815. doi: 10.1016/j.phrs.2025.107815. Epub 2025 Jun 5.

引用本文的文献

1
Protective Role of Luteolin against Endothelial Ferroptosis: Linking Antioxidant Pathways To Vascular Health.木犀草素对内皮细胞铁死亡的保护作用:将抗氧化途径与血管健康联系起来
Cell Biochem Biophys. 2025 Sep 12. doi: 10.1007/s12013-025-01892-2.

本文引用的文献

1
A hollow nanozyme-based multifunctional platform enhances sonodynamic-chemodynamic-induced ferroptosis for cancer therapy.基于中空纳米酶的多功能平台增强声动力-化学动力诱导的铁死亡用于癌症治疗。
RSC Adv. 2025 Mar 27;15(12):9408-9419. doi: 10.1039/d5ra00032g. eCollection 2025 Mar 21.
2
Ferroptosis: a potential therapeutic target in cardio-cerebrovascular diseases.铁死亡:心脑血管疾病的潜在治疗靶点。
Mol Cell Biochem. 2025 Mar 27. doi: 10.1007/s11010-025-05262-7.
3
Insights into emerging mechanisms of ferroptosis: new regulators for cancer therapeutics.
铁死亡新兴机制的见解:癌症治疗的新调控因子
Cell Biol Toxicol. 2025 Mar 25;41(1):63. doi: 10.1007/s10565-025-10010-0.
4
Endothelial but not systemic ferroptosis inhibition protects from antineutrophil cytoplasmic antibody-induced crescentic glomerulonephritis.内皮细胞而非全身铁死亡抑制可预防抗中性粒细胞胞浆抗体诱导的新月体性肾小球肾炎。
Kidney Int. 2025 Jun;107(6):1037-1050. doi: 10.1016/j.kint.2025.02.023. Epub 2025 Mar 22.
5
The dynamic role of ferroptosis in cancer immunoediting: Implications for immunotherapy.铁死亡在癌症免疫编辑中的动态作用:对免疫治疗的启示。
Pharmacol Res. 2025 Apr;214:107674. doi: 10.1016/j.phrs.2025.107674. Epub 2025 Feb 26.
6
Increased Trophoblast Cell Ferroptosis via HMGB1/ACSL4 Pathway Is Associated with Spontaneous Abortion.通过HMGB1/ACSL4途径增加的滋养层细胞铁死亡与自然流产有关。
Reprod Sci. 2025 May;32(5):1713-1722. doi: 10.1007/s43032-025-01817-7. Epub 2025 Feb 24.
7
Synchronously Delivering Melittin and Evoking Ferroptosis via Tumor Microenvironment-Triggered Self-Destructive Metal-Organic Frameworks to Boost Cancer Immunotherapy.通过肿瘤微环境触发的自毁性金属有机框架同步递送蜂毒肽并引发铁死亡以增强癌症免疫治疗
Adv Healthc Mater. 2025 Apr;14(11):e2500003. doi: 10.1002/adhm.202500003. Epub 2025 Feb 24.
8
Oxazole-Based Ferroptosis Inhibitors with Promising Properties to Treat Central Nervous System Diseases.具有治疗中枢神经系统疾病潜力的基于恶唑的铁死亡抑制剂。
J Med Chem. 2025 Feb 27;68(4):4908-4928. doi: 10.1021/acs.jmedchem.4c03149. Epub 2025 Feb 6.
9
Acceptor Elongation Boosted Intersystem Crossing Affords Efficient NIR Type-I and AIE-Active Photosensitizers for Targeting Ferroptosis-Based Cancer Therapy.受体延长增强系间窜越可提供用于靶向铁死亡癌症治疗的高效近红外I型和聚集诱导发光活性光敏剂。
Adv Healthc Mater. 2025 Mar;14(7):e2404505. doi: 10.1002/adhm.202404505. Epub 2025 Jan 19.
10
Cell-membrane targeting sonodynamic therapy combination with FSP1 inhibition for ferroptosis-boosted immunotherapy.细胞膜靶向声动力疗法联合FSP1抑制用于增强铁死亡的免疫治疗。
Mater Today Bio. 2024 Dec 15;30:101407. doi: 10.1016/j.mtbio.2024.101407. eCollection 2025 Feb.